Initial data on the bioactivity of the developed ZnO-NPs materials indicated a successful inhibition of the growth of Aspergillus niger, already at low NPs concentrations.
The diffraction spectra of Coll HA and Coll HA/BT composite materials indicate a pronounced interaction between Col and the mineral phases, meaning a good mineralization of Col fibres.
As shown in Figure 3 and Table 1, the smaller intensity ratio of D to G band (ID/IG) and full width at half maximum (FWHM) of the G band, as well as the slightly higher IG'/IG of MWCNT-VAST compared to the other two MWCNT materials indicate a higher degree of graphitization, which is in agreement with the XRD result.
Whatever the alloys, SEM investigations performed before and after cycling do not reveal any significant difference between the original material and the cycled material, indicating a good stability of the electrodeposited films upon cycling.
Calcium phosphate precipitation was observed on the surface of the as-polished material, indicating a degree of bioactivity of the as-polished surface which is absent in the TiN coated substrate alloy.
After paclitaxel exposure, the GaMg and the D-54Mg cells exhibited a fragmentation of the nuclear material, indicating a possible induction of apoptosis.
The virulence gene profiles were highly conserved within most of the emm types in our material, indicating a link between emm type and phage preference.
Based on these criteria there were 440 transcripts with complete coding sequences (cCDS FLIcs) in our material, indicating a success rate of about 79%.
In the kidneys of high salt DSS rats, more than 75% of the area of the glomerular capillaries can be filled with matrix material, indicating a high degree of glomerular injury [ 13].
For several CYP substrates, CL ranged about fourfold between clinical subjects, whereas in vitro, CYP activities were found to range from 30- to 100-fold (depending on the CYP) for either microsomes or hepatocytes (in a database of commercially available material), indicating a wide inherent in vitro variation (Hallifax and Houston 2009).
